Idera Pharmaceuticals Announces Change of Location for 2020 Annual Meeting of Stockholders

    NEXT STORY
    Outlook on the Worldwide Research Antibodies Industry to 2024 – Mergers, Acquisitions, Agreements and Collaborations
    PREV STORY
    Akari Therapeutics Announces Positive Topline Results from Fully Recruited Phase II Study of Nomacopan in Bullous Pemphigoid Patients
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    VALNEVA Announces its Intention to Delist from the Vienna Stock Exchange

    Valneva Announces its Intention to Delist from the Vienna Stock Exchange  Trading will be ...

    author_avatar
    NASDAQ Market News

    Timothy Keeler, BS-PA is Selected to the American Health Council’s Board of Physicians

    NEW YORK, Aug. 14, 2018 (GLOBE NEWSWIRE) -- The American Health Council selected Timothy ...

    author_avatar
    NASDAQ Market News

    CytomX Announces Fourth Target Selection by Bristol-Myers Squibb Under Strategic Oncology Collaboration

    SOUTH SAN FRANCISCO, Calif., Dec. 05, 2016 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), ...

    author_avatar
    NASDAQ Market News